A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

CES isn’t a big smartphone show, but there have been more new handsets here than I expected. Samsung gave us our first ...

The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...

The cell company sponsors races in Las Vegas and—coming in 2026—Austin, rolling out Gen Z influencers and fan experiences for ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy ...

An early proof-of-concept demo of Meta's neural gesture band connected to Garmin's smart car interface is the company's next ...

CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells ...

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2025 /PRNewswire/ -- Link Cell Therapies ("Link"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited ...